Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China · Delayed Price · Currency is CNY 7.96
-0.07 (-0.87%)
Nov 6, 2026, 3:00 PM CST
SHA:600867 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,219 | 1,434 | 590.2 | 1,104 | 788.06 | 865.04 |
Trading Asset Securities | 415.55 | 63.22 | 55.4 | 55.52 | 58.46 | 37 |
Cash & Short-Term Investments | 1,634 | 1,497 | 645.6 | 1,160 | 846.52 | 902.04 |
Cash Growth | -1.51% | 131.89% | -44.33% | 37.00% | -6.15% | 21.28% |
Accounts Receivable | 547.41 | 483.16 | 547.57 | 869.74 | 455.99 | 650.94 |
Other Receivables | 48.89 | 10.52 | 7.88 | 8.79 | 20.56 | 7.63 |
Receivables | 596.3 | 493.69 | 555.45 | 878.53 | 476.55 | 658.57 |
Inventory | 634.54 | 704.22 | 736.31 | 705.35 | 653.9 | 537.92 |
Prepaid Expenses | - | - | - | - | 0.02 | 0.03 |
Other Current Assets | 98.4 | 51.76 | 72.56 | 72.76 | 79.43 | 63.9 |
Total Current Assets | 2,963 | 2,747 | 2,010 | 2,816 | 2,056 | 2,162 |
Property, Plant & Equipment | 2,380 | 2,537 | 2,732 | 2,671 | 2,678 | 2,392 |
Long-Term Investments | 614.36 | 569.27 | 627.75 | 435.01 | 362.49 | 457.91 |
Other Intangible Assets | 547.29 | 547.98 | 628.05 | 670.02 | 487.01 | 389.07 |
Long-Term Deferred Tax Assets | 51.17 | 66.35 | 142.91 | 38.55 | 46.19 | 42.41 |
Long-Term Deferred Charges | 1,238 | 1,152 | 977.32 | 690.91 | 607.25 | 447.29 |
Other Long-Term Assets | 273.71 | 286.97 | 264.08 | 449.84 | 513.13 | 628.85 |
Total Assets | 8,068 | 7,906 | 7,382 | 7,771 | 6,750 | 6,520 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 88.23 | 91.1 | 96.71 | 115.9 | 80.86 | 75 |
Accrued Expenses | 54.85 | 19.57 | 51.95 | 30.93 | 11.03 | 31.74 |
Short-Term Debt | 317.76 | 33.02 | 416.76 | 150 | - | - |
Current Portion of Long-Term Debt | 87.16 | 266.75 | - | - | - | - |
Current Portion of Leases | - | 8.59 | 4.4 | - | - | - |
Current Income Taxes Payable | - | 1.71 | 0.08 | 52.46 | - | 80.45 |
Current Unearned Revenue | 15.3 | 8.72 | 16.07 | 10.48 | 21.08 | 7.89 |
Other Current Liabilities | 143.18 | 116.04 | 80.68 | 160.39 | 49.08 | 73.47 |
Total Current Liabilities | 706.47 | 545.51 | 666.65 | 520.16 | 162.05 | 268.55 |
Long-Term Debt | 216.25 | 192.19 | 253.49 | - | 2.65 | 2.65 |
Long-Term Leases | 37.41 | 25.33 | 19.5 | - | - | - |
Long-Term Unearned Revenue | 29.22 | 28.41 | 27.66 | 27.51 | 28.53 | 28.67 |
Long-Term Deferred Tax Liabilities | 19.88 | 7.4 | 11.99 | 7.41 | 7.51 | - |
Total Liabilities | 1,009 | 798.84 | 979.29 | 555.08 | 200.74 | 299.87 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,959 | 1,959 | 1,982 | 1,994 | 1,994 | 2,034 |
Additional Paid-In Capital | - | 301.67 | 509.32 | 622.56 | 641.9 | 1,006 |
Retained Earnings | 4,850 | 4,920 | 4,187 | 4,725 | 4,053 | 3,567 |
Treasury Stock | -73.12 | -88.11 | -300.28 | -134.83 | -150.37 | -398.13 |
Comprehensive Income & Other | 354.92 | 10.67 | 6.91 | 5.28 | 6.39 | 6.94 |
Total Common Equity | 7,090 | 7,103 | 6,385 | 7,211 | 6,544 | 6,215 |
Minority Interest | -31.35 | 4.42 | 17.96 | 5.09 | 5.31 | 5.35 |
Shareholders' Equity | 7,059 | 7,108 | 6,403 | 7,216 | 6,550 | 6,220 |
Total Liabilities & Equity | 8,068 | 7,906 | 7,382 | 7,771 | 6,750 | 6,520 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 658.58 | 525.89 | 694.15 | 150 | 2.65 | 2.65 |
Net Cash (Debt) | 975.64 | 971.17 | -48.55 | 1,010 | 843.87 | 899.39 |
Net Cash Growth | 11.26% | - | - | 19.65% | -6.17% | 21.36% |
Net Cash Per Share | 0.50 | 0.49 | -0.02 | 0.51 | 0.42 | 0.44 |
Filing Date Shares Outstanding | 1,895 | 1,956 | 1,754 | 1,916 | 1,984 | 2,018 |
Total Common Shares Outstanding | 1,895 | 1,956 | 1,754 | 1,916 | 1,984 | 2,018 |
Working Capital | 2,257 | 2,201 | 1,343 | 2,296 | 1,894 | 1,894 |
Book Value Per Share | 3.74 | 3.63 | 3.64 | 3.76 | 3.30 | 3.08 |
Tangible Book Value | 6,543 | 6,555 | 5,757 | 6,541 | 6,057 | 5,826 |
Tangible Book Value Per Share | 3.45 | 3.35 | 3.28 | 3.41 | 3.05 | 2.89 |
Buildings | - | 1,820 | 1,829 | 1,437 | 1,452 | 1,305 |
Machinery | - | 2,375 | 2,356 | 1,532 | 1,591 | 1,301 |
Construction In Progress | - | 169.5 | 226.11 | 1,319 | 1,158 | 1,203 |